期刊文献+

综合医疗机构抗菌药物临床应用管理对策探讨 被引量:4

Strategies for Clinical Use and Management of Antibacterial Agents in Integrated Medical Institutions
原文传递
导出
摘要 目的:探讨我院为合理使用抗菌药物采取的干预措施,为综合医疗机构制定相关措施提供参考。方法:按原卫生部"抗菌药物临床应用专项整治活动"的相关要求,阐述我院为促进临床抗菌药物合理使用制定的相关措施。结果与结论:为确保临床抗菌药物的合理使用,医疗机构制定的相关干预措施应涵盖组织与制度建设、人员培训、处方医嘱审核与点评及其信息反馈、抗菌药物临床应用预警及网络监测等诸多环节;其制度建设等相关干预措施需在实践过程中不断修正与完善,使之持续改进、日臻完善,在促进临床抗菌药物合理应用中发挥积极作用。 OBJECTIVE: To explore the intervention measures for rational use of antibacterial agents in our hospital in order to provide reference for the development of relevant measures in integrated medical institutions. METHODS: According to the rele- vant requirements of "special rectification activities for clinical use of antibiotics" by the Ministry of Public Health, the measures ~,nacted to promote the rational use of antibacterial drugs in our hospital were interpreted. RESULTS&CONCLUSIONS: In order to ensure the rational use of antibacterial agents, the relevant intervention measures enacted by medical institutions should cover the following aspects as organization and system construction, personnel training, prescription and medical records checking and re- views, their information feedback, early warning and network monitoring for clinical use of antibiotics, etc. The system construc- tion and other related interventions measures should be constantly revised and improved in the practice, so that they can play a bet- ter role in the promotion of rational use of antibacterial agents in the clinic.
出处 《中国药房》 CAS CSCD 2014年第38期3640-3642,共3页 China Pharmacy
关键词 综合医疗机构 抗菌药物 合理应用 干预措施 Integrated medical institutions Antibacterial agent Rational use Intervention measures
  • 相关文献

参考文献8

  • 1刘军,宫凯敏,赵培.用药干预对抗菌药物临床合理应用的影响[J].中国药事,2013,27(2):225-228. 被引量:8
  • 2卫生部,国家中医药管理局.抗菌药物临床应用指导原则[S].2004:8~19
  • 3卫生部.卫生部办公厅关于进一步加强抗菌药物临床应用管理的通知[S].2009-03-23.
  • 4卫生部.2011年全国抗菌药物临床应用专项整治活动方案[S].北京:中华人民共和国卫生部,2011:56.
  • 5卫生部.抗菌药物临床应用管理办法[S].2012-04-24.
  • 6卫生部.2012年全国抗菌药物临床应用专项整治活动督导检查手册[S].2012-10.
  • 7四川省卫生厅.四川省卫生厅关于印发四川省抗菌药物临床应用分级管理目录(试行)的通知[S].2012-10-18.
  • 8孙浩,徐英宏,肇丽梅,王大南,菅凌燕.临床药师在抗菌药物剂量调整中的作用[J].中国药房,2013,24(26):2483-2485. 被引量:2

二级参考文献14

  • 1卫生部.抗菌药物临床应用指导原则[z].2004-10-9.
  • 2卫生部.关于印发《医院处方点评管理规范(试行)》的通知[Z].卫医管发[2010]28号,20lO.
  • 3卫生部.2012年全国抗菌药物临床应用专项整治活动方案[Z].2012-03-06.
  • 4卫生部.卫生部办公厅关于进一步加强抗菌药物临床应用管理的通知[z].卫医发[2009]38号,2009.
  • 5Huang CR,Chen SF,Lu CH,et al.Clinical characteris-tics and therapeutic outcomes of nosocomial super-infec-tion in adult bacterial meningitis[J].BMC Infect Dis,2011,11(1):133.
  • 6Sociétéde Pathologie Infectieuse de Langue Fran aise(SP-ILF).Practice guidelines for acute bacterial meningitidis(except newborn and nosocomial meningitis)[J].Med Mal Infect,2009,39(6):356.
  • 7Rybak M,Lomaestro B,Rotschafer JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensusreview of the american society of health-system pharma-cists,the infectious diseases society of america,and the society of infectious diseases pharmacists[J].Am J Health Syst Pharm,2009,66(1):82.
  • 8Wang KW,Chang WN,Huang CR,et al.Post-neurosur-gical nosocomial bacterial meningitis in adults:microbiol-ogy,clinical features,and outcomes[J].J Clin Neurosci,2005,12(6):647.
  • 9Van de Beek D,Brouwer MC,Thwaites GE,et al.Ad-vances in treatment of bacterial meningitis[J].Lancet,2012,380(9854):1693.
  • 10Mohr JF.Update on the efficacy and tolerability of me-ropenem in the treatment of serious bacterial infections[J].Clin Infect Dis,2008,47(S1):41.

共引文献186

同被引文献26

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部